Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-23
2007-01-23
Jiang, Shaojia (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S349000, C514S326000, C546S207000, C546S218000
Reexamination Certificate
active
10374299
ABSTRACT:
Sulfonamide lactams of the following formulawherein X, R1, R2, R3, R4, R4a, R5, R5a, R6, R6a, R7and R8are as described herein, are provided which inhibitors of Factor Xa and are useful as anticoagulants in the treatment of cardiovascular diseases associated with thromboses.
REFERENCES:
patent: 5164388 (1992-11-01), De et al.
patent: 5489583 (1996-02-01), Mack et al.
patent: 5502032 (1996-03-01), Haupt et al.
patent: 5541343 (1996-07-01), Himmelsbach et al.
patent: 5591769 (1997-01-01), Himmelsbach et al.
patent: 5612353 (1997-03-01), Ewing et al.
patent: 5714499 (1998-02-01), Semple et al.
patent: 5719296 (1998-02-01), Acton, III et al.
patent: 5932733 (1999-08-01), Semple et al.
patent: 5981490 (1999-11-01), Baxter et al.
patent: 6034215 (2000-03-01), Semple et al.
patent: 6136834 (2000-10-01), Ohmoto et al.
patent: 6281227 (2001-08-01), Choi-Sledeski et al.
patent: 0519433 (1992-06-01), None
patent: 09165370 (1997-06-01), None
patent: WO89/10961 (1989-11-01), None
patent: WO90/04917 (1990-05-01), None
patent: WO90/05531 (1990-05-01), None
patent: WO92/10509 (1992-06-01), None
patent: WO92/10510 (1992-06-01), None
patent: WO93/01208 (1993-01-01), None
patent: WO95/35311 (1995-12-01), None
patent: WO95/35313 (1995-12-01), None
patent: WO96/40679 (1996-12-01), None
patent: WO97/14417 (1997-04-01), None
patent: WO97/30073 (1997-08-01), None
patent: WO97/31937 (1997-09-01), None
patent: WO97/31939 (1997-09-01), None
patent: WO98/00401 (1998-01-01), None
patent: WO98/08840 (1998-03-01), None
patent: WO98/16523 (1998-04-01), None
patent: WO98/46220 (1998-10-01), None
patent: WO98/47876 (1998-10-01), None
patent: WO98/50420 (1998-11-01), None
patent: WO00/05243 (2000-03-01), None
patent: WO00/44733 (2000-08-01), None
patent: WO01/19795 (2001-03-01), None
Biochemistry, 1998, 37(35), 12094-12103.
J. Med. Chem. 1993, 36, 300-303.
Goodman and Gilman's “The Pharmacological Basis of Therapeutics”, 10th Ed., 1996, pp. 54-57.
Siev, et al. (2000) Organic Letters vol. 2, No. 1, pp. 19-22.
Ewing et al., (1999) J. Med. Chem. vol. 42, pp. 3557-3571.
Reiner et al., (1999) Bioorganic & Medicinal Chemistry Letters 9, pp. 895-900.
Owens et al., (1998) Bioorganic & Medicinal Chemistry Letters 8, pp. 3683-3688.
Semple, J. Edward (1998) Bioorganic & Medicinal Chemistry Letters 8, pp. 2501-2506.
Nutt, et al., (1996) Peptides, pp. 71-74.
Semple, J. Edward (1998) Tetrahedron Letters 39, pp. 6645-6648.
Krishnan, et al. (1998) Biochemistry, vol. 37, pp. 12094-12103.
Semple et al., (1997) Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 18, pp. 2421-2426.
Klingler et al., (1997) Biophysical Journal, vol. 73, pp. 2195-2200.
Levy et al., (1996) Journal of Medicinal Chemistry, vol. 39, No. 23, pp. 4527-4530.
Semple et al., (1996) J. Med. Chem., vol. 39, pp. 4531-4536.
Okayama et al., (1995) Chem. Pharm. Bull., vol. 43, No. 10, pp. 1683-1691.
Mack et al., (1995) J. Enzyme Inhibition, vol. 9, pp. 73-86.
Tamura et al., (1997) Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 3, pp. 331-336.
Semple et al., (1998) Bioorganic & Medicinal Chemistry Letters 8, pp. 3525-3530.
Semple et al. (2000) Organic Letters, vol. 2, No. 18, pp. 2769-2772.
Lawrence Michael
O'Connor Stephen P.
Shi Yan
Stein Philip D.
Bristol Myers Squibb Co.
Davis Stephen B.
Hermenau Ronald S.
Jiang Shaojia
Krishnan Ganapathy
LandOfFree
Sulfonamide lactam inhibitors of FXa and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonamide lactam inhibitors of FXa and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamide lactam inhibitors of FXa and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3733826